Viral deubiquitinases: role in evasion of anti-viral innate immunity

References

• Akutsu M, Ye Y, Virdee S, Chin JW, Komander D. 2011. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc Natl Acad Sci USA. 108:2228–2233.
   PubMed Web of Science ®Google Scholar
• Arimoto K, Funami K, Saeki Y, Tanaka K, Okawa K, Takeuchi O, Akira S, Murakami Y, Shimotohno K. 2010. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc Natl Acad Sci USA. 107:15856–15861.
   PubMed Web of Science ®Google Scholar
• Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. 2007. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA. 104:7500–7505.
   PubMed Web of Science ®Google Scholar
• Bailey-Elkin BA, Knaap RC, Johnson GG, Dalebout TJ, Ninaber DK, van Kasteren PB, Bredenbeek PJ, Snijder EJ, Kikkert M, Mark BL. 2014. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem. 289:34667–34682.
   PubMed Web of Science ®Google Scholar
• Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS Jr. 1992. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6:1899–1913.
   PubMed Web of Science ®Google Scholar
• Belgnaoui SM, Paz S, Samuel S, Goulet ML, Sun Q, Kikkert M, Iwai K, Dikic I, Hiscott J, Lin R. 2012. Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex. Cell Host Microbe. 12:211–222.
   PubMed Web of Science ®Google Scholar
• Bhat N, Fitzgerald KA. 2014. Recognition of cytosolic DNA by cGAS and other STING-dependent sensors. Eur J Immunol. 44:634–640.
   PubMed Web of Science ®Google Scholar
• Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, et al. 2004. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 5:1052–1060.
   PubMed Web of Science ®Google Scholar
• Borrego B, Rodriguez-Pulido M, Revilla C, Alvarez B, Sobrino F, Dominguez J, Saiz M. 2015. Synthetic RNAs mimicking structural domains in the foot-and-mouth disease virus genome elicit a broad innate immune response in porcine cells triggered by RIG-I and TLR activation. Viruses. 7:3954–3973.
   PubMed Web of Science ®Google Scholar
• Bowling BL, Adamson AL. 2006. Functional interactions between the Epstein-Barr virus BZLF1 protein and the promyelocytic leukemia protein. Virus Res. 117:244–253.
   PubMed Web of Science ®Google Scholar
• Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 478:515–518.
   PubMed Web of Science ®Google Scholar
• Chan YK, Gack MU. 2015. RIG-I-like receptor regulation in virus infection and immunity. Curr Opin Virol. 12:7–14.
   PubMed Web of Science ®Google Scholar
• Chen R, Zhang L, Zhong B, Tan B, Liu Y, Shu HB. 2010. The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. Cell Res. 20:802–811.
   PubMed Web of Science ®Google Scholar
• Chen X, Yang X, Zheng Y, Yang Y, Xing Y, Chen Z. 2014. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. Protein Cell. 5:369–381.
   PubMed Web of Science ®Google Scholar
• Colleran A, Collins PE, O’Carroll C, Ahmed A, Mao X, McManus B, Kiely PA, Burstein E, Carmody RJ. 2013. Deubiquitination of NF-kappaB by ubiquitin-specific protease-7 promotes transcription. Proc Natl Acad Sci USA. 110:618–623.
   PubMed Web of Science ®Google Scholar
• Cui J, Song Y, Li Y, Zhu Q, Tan P, Qin Y, Wang HY, Wang RF. 2014. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 24:400–416.
   PubMed Web of Science ®Google Scholar
• Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA. 2005. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem. 280:36560–36566.
   PubMed Web of Science ®Google Scholar
• Daubeuf S, Singh D, Tan Y, Liu H, Federoff HJ, Bowers WJ, Tolba K. 2009. HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood. 113:3264–3275.
   PubMed Web of Science ®Google Scholar
• Davis ME, Gack MU. 2015. Ubiquitination in the antiviral immune response. Virology. 479–480:52–65.
   PubMed Web of Science ®Google Scholar
• de Los Santos T, Diaz-San Segundo F, Grubman MJ. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol. 81:12803–12815.
   PubMed Web of Science ®Google Scholar
• Devhare PB, Desai S, Lole KS. 2016. Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies. Sci Rep. 6:26827.
   PubMed Web of Science ®Google Scholar
• Durcan TM, Tang MY, Perusse JR, Dashti EA, Aguileta MA, McLelland GL, Gros P, Shaler TA, Faubert D, Coulombe B, et al. 2014. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J. 33:2473–2491.
   PubMed Web of Science ®Google Scholar
• Elia AE, Boardman AP, Wang DC, Huttlin EL, Everley RA, Dephoure N, Zhou C, Koren I, Gygi SP, Elledge SJ. 2015. Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response. Mol Cell. 59:867–881.
   PubMed Web of Science ®Google Scholar
• Fan Y, Mao R, Yu Y, Liu S, Shi Z, Cheng J, Zhang H, An L, Zhao Y, Xu X, et al. 2014. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J Exp Med. 211:313–328.
   PubMed Web of Science ®Google Scholar
• Feng W, Sun X, Shi N, Zhang M, Guan Z, Duan M. 2017. Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response. Biochem Biophys Res Commun. 482:1107–1113.
   PubMed Web of Science ®Google Scholar
• Foeger N, Glaser W, Skern T. 2002. Recognition of eukaryotic initiation factor 4G isoforms by picornaviral proteinases. J Biol Chem. 277:44300–44309.
   PubMed Web of Science ®Google Scholar
• Frias-Staheli N, Giannakopoulos NV, Kikkert M, Taylor SL, Bridgen A, Paragas J, Richt JA, Rowland RR, Schmaljohn CS, Lenschow DJ, et al. 2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe. 2:404–416.
   PubMed Web of Science ®Google Scholar
• Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS, Moran TM, Basler CF, Komuro A, Horvath CM, et al. 2008. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9:930–936.
   PubMed Web of Science ®Google Scholar
• Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 5:439–449.
   PubMed Web of Science ®Google Scholar
• Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 446:916–920.
   PubMed Web of Science ®Google Scholar
• Gale M Jr, Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature. 436:939–945.
   PubMed Web of Science ®Google Scholar
• Gerlier D, Valentin H. 2009. Measles virus interaction with host cells and impact on innate immunity. Curr Top Microbiol Immunol. 329:163–191.
   PubMed Web of Science ®Google Scholar
• Gonzalez CM, Wang L, Damania B. 2009. Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase. J Virol. 83:10224–10233.
   PubMed Web of Science ®Google Scholar
• Gradi A, Foeger N, Strong R, Svitkin YV, Sonenberg N, Skern T, Belsham GJ. 2004. Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the l-protease cleavage site in vitro. J Virol. 78:3271–3278.
   PubMed Web of Science ®Google Scholar
• Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Hacker G, et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 439:204–207.
   PubMed Web of Science ®Google Scholar
• Hale BG, Albrecht RA, Garcia-Sastre A. 2010. Innate immune evasion strategies of influenza viruses. Future Microbiol. 5:23–41.
   PubMed Web of Science ®Google Scholar
• Harhaj EW, Dixit VM. 2011. Deubiquitinases in the regulation of NF-κB signaling. Cell Res. 21:22–39.
   PubMed Web of Science ®Google Scholar
• He X, Li Y, Li C, Liu LJ, Zhang XD, Liu Y, Shu HB. 2013. USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6. J Mol Cell Biol. 5:39–47.
   PubMed Web of Science ®Google Scholar
• Heaton SM, Borg NA, Dixit VM. 2016. Ubiquitin in the activation and attenuation of innate antiviral immunity. J Exp Med. 213:1–13.
   PubMed Web of Science ®Google Scholar
• Hilterbrand AT, Boutz DR, Marcotte EM, Upton JW. 2017. Murine cytomegalovirus deubiquitinase regulates viral chemokine levels to control inflammation and pathogenesis. MBio. 8:e01864-16.
   PubMed Web of Science ®Google Scholar
• Hu H, Sun SC. 2016. Ubiquitin signaling in immune responses. Cell Res. 26:457–483.
   PubMed Web of Science ®Google Scholar
• Huffmaster NJ, Sollars PJ, Richards AL, Pickard GE, Smith GA. 2015. Dynamic ubiquitination drives herpesvirus neuroinvasion. Proc Natl Acad Sci USA. 112:12818–12823.
   PubMed Web of Science ®Google Scholar
• Inn KS, Lee SH, Rathbun JY, Wong LY, Toth Z, Machida K, Ou JH, Jung JU. 2011. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J Virol. 85:10899–10904.
   PubMed Web of Science ®Google Scholar
• Jiang J, Tang H. 2010. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Protein Cell. 1:1106–1117.
   PubMed Web of Science ®Google Scholar
• Jin S, Tian S, Chen Y, Zhang C, Xie W, Xia X, Cui J, Wang RF. 2016. USP19 modulates autophagy and antiviral immune responses by deubiquitinating Beclin-1. EMBO J. 35:866–880.
   PubMed Web of Science ®Google Scholar
• Kalra N, Kumar V. 2006. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc. FEBS Lett. 580:431–436.
   PubMed Web of Science ®Google Scholar
• Kanarek N, London N, Schueler-Furman O, Ben-Neriah Y. 2010. Ubiquitination and degradation of the inhibitors of NF-kappaB. Cold Spring Harb Perspect Biol. 2:a000166.
   PubMed Web of Science ®Google Scholar
• Karim R, Tummers B, Meyers C, Biryukov JL, Alam S, Backendorf C, Jha V, Offringa R, van Ommen GJ, Melief CJ, et al. 2013. Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response. PLoS Pathog. 9:e1003384.
   PubMed Web of Science ®Google Scholar
• Kattenhorn LM, Korbel GA, Kessler BM, Spooner E, Ploegh HL. 2005. A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol Cell. 19:547–557.
   PubMed Web of Science ®Google Scholar
• Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, et al. 2004. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol. 5:1061–1068.
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, O'Rourke KM, Eby M, Pietras E, Cheng G, Bazan JF, et al. 2007. DUBA: a deubiquitinase that regulates type I interferon production. Science. 318:1628–1632.
   PubMed Web of Science ®Google Scholar
• Kong L, Shaw N, Yan L, Lou Z, Rao Z. 2015. Structural view and substrate specificity of papain-like protease from avian infectious bronchitis virus. J Biol Chem. 290:7160–7168.
   PubMed Web of Science ®Google Scholar
• Kulathu Y, Komander D. 2012. Atypical ubiquitylation – the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol. 13:508–523.
   PubMed Web of Science ®Google Scholar
• Kumar H, Kawai T, Akira S. 2009. Pathogen recognition in the innate immune response. Biochem J. 420:1–16.
   PubMed Web of Science ®Google Scholar
• Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL, et al. 2007. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol. 179:935–950.
   PubMed Web of Science ®Google Scholar
• Kumari P, Narayanan S, Kumar H. 2015. Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways. Rev Med Virol. 25:187–201.
   PubMed Web of Science ®Google Scholar
• Kumari P, Saha I, Narayanan A, Narayanan S, Takaoka A, Kumar NS, Tailor P, Kumar H. 2017. Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways. Cell Death Dis. https://doi.org/10.1038/cddis.2017.461.
   PubMed Web of Science ®Google Scholar
• Kwon KM, Oh SE, Kim YE, Han TH, Ahn JH. 2017. Cooperative inhibition of RIP1-mediated NF-κB signaling by cytomegalovirus-encoded deubiquitinase and inactive homolog of cellular ribonucleotide reductase large subunit. PLoS Pathog. 13:e1006423.
   PubMed Web of Science ®Google Scholar
• Lee S, Kim W, Ko C, Ryu WS. 2015. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis. Oncogene. 35:1857–1867.
   PubMed Web of Science ®Google Scholar
• Li S, Zheng H, Mao AP, Zhong B, Li Y, Liu Y, Gao Y, Ran Y, Tien P, Shu HB. 2010. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem. 285:4291–4297.
   PubMed Web of Science ®Google Scholar
• Li SW, Wang CY, Jou YJ, Huang SH, Hsiao LH, Wan L, Lin YJ, Kung SH, Lin CW. 2016. SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6. IJMS Sci. 17:678.
   Google Scholar
• Lin M, Zhao Z, Yang Z, Meng Q, Tan P, Xie W, Qin Y, Wang RF, Cui J. 2016. USP38 inhibits type I interferon signaling by editing TBK1 ubiquitination through NLRP4 signalosome. Mol Cell. 64:267–281.
   PubMed Web of Science ®Google Scholar
• Lin R, Yang L, Nakhaei P, Sun Q, Sharif-Askari E, Julkunen I, Hiscott J. 2006. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem. 281:2095–2103.
   PubMed Web of Science ®Google Scholar
• Lindner HA. 2007. Deubiquitination in virus infection. Virology. 362:245–256.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li J, Chen J, Li Y, Wang W, Du X, Song W, Zhang W, Lin L, Yuan Z. 2015. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J Virol. 89:2287–2300.
   PubMed Web of Science ®Google Scholar
• Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 82:335–345.
   PubMed Web of Science ®Google Scholar
• Maelfait J, Beyaert R. 2012. Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev: MMBR. 76:33–45.
   PubMed Web of Science ®Google Scholar
• Maelfait J, Roose K, Bogaert P, Sze M, Saelens X, Pasparakis M, Carpentier I, van Loo G, Beyaert R. 2012. A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection. PLoS Pathog. 8:e1002570.
   PubMed Web of Science ®Google Scholar
• Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ. 2014. Hepatitis E virus inhibits type I interferon induction by ORF1 products. J Virol. 88:11924–11932.
   PubMed Web of Science ®Google Scholar
• Ning S, Pagano JS. 2010. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J Virol. 84:6130–6138.
   PubMed Web of Science ®Google Scholar
• Ordureau A, Heo JM, Duda DM, Paulo JA, Olszewski JL, Yanishevski D, Rinehart J, Schulman BA, Harper JW. 2015. Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc Natl Acad Sci USA. 112:6637–6642.
   PubMed Web of Science ®Google Scholar
• Oshiumi H, Miyashita M, Matsumoto M, Seya T. 2013. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9:e1003533.
   PubMed Web of Science ®Google Scholar
• Perez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, Herman M, Cardon A, Durandy A, Bustamante J, et al. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity. 33:400–411.
   PubMed Web of Science ®Google Scholar
• Qin Y, Zhou MT, Hu MM, Hu YH, Zhang J, Guo L, Zhong B, Shu HB. 2014. RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms. PLoS Pathog. 10:e1004358.
   PubMed Web of Science ®Google Scholar
• Rajsbaum R, Garcia-Sastre A. 2013. Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways. Trends Microbiol. 21:421–429.
   PubMed Web of Science ®Google Scholar
• Ratia K, Saikatendu KS, Santarsiero BD, Barretto N, Baker SC, Stevens RC, Mesecar AD. 2006. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci USA. 103:5717–5722.
   PubMed Web of Science ®Google Scholar
• Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A, Kawashima D, Tsurumi T. 2013. Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-kappaB signaling during productive replication. J Virol. 87:4060–4070.
   PubMed Web of Science ®Google Scholar
• Sato S, Li K, Kameyama T, Hayashi T, Ishida Y, Murakami S, Watanabe T, Iijima S, Sakurai Y, Watashi K, et al. 2015. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity. 42:123–132.
   PubMed Web of Science ®Google Scholar
• Saxena N, Kumar V. 2014. The HBx oncoprotein of hepatitis B virus deregulates the cell cycle by promoting the intracellular accumulation and re-compartmentalization of the cellular deubiquitinase USP37. PLoS One. 9:e111256.
   PubMed Web of Science ®Google Scholar
• Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. 2000. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem. 275:25858–25864.
   PubMed Web of Science ®Google Scholar
• Snijder EJ, Wassenaar AL, Spaan WJ, Gorbalenya AE. 1995. The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J Biol Chem. 270:16671–16676.
   PubMed Web of Science ®Google Scholar
• Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol. 79:2689–2699.
   PubMed Web of Science ®Google Scholar
• Sun C, Schattgen SA, Pisitkun P, Jorgensen JP, Hilterbrand AT, Wang LJ, West JA, Hansen K, Horan KA, Jakobsen MR, et al. 2015. Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection. J Immunol. 194:1819–1831.
   PubMed Web of Science ®Google Scholar
• Sun H, Zhang Q, Jing YY, Zhang M, Wang HY, Cai Z, Liuyu T, Zhang ZD, Xiong TC, Wu Y, et al. 2017. USP13 negatively regulates antiviral responses by deubiquitinating STING. Nat Commun. 8:15534.
   PubMed Web of Science ®Google Scholar
• Sun Z, Chen Z, Lawson SR, Fang Y. 2010. The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J Virol. 84:7832–7846.
   PubMed Web of Science ®Google Scholar
• Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 448:501–505.
   PubMed Web of Science ®Google Scholar
• Tseng PH, Matsuzawa A, Zhang W, Mino T, Vignali DA, Karin M. 2010. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol. 11:70–75.
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, Matsuura Y, Kawai T, Akira S. 2010. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity. 33:765–776.
   PubMed Web of Science ®Google Scholar
• Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 11:997–1004.
   PubMed Web of Science ®Google Scholar
• van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, et al. 2014. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. PLoS Pathog. 10:e1003960.
   PubMed Web of Science ®Google Scholar
• van Kasteren PB, Bailey-Elkin BA, James TW, Ninaber DK, Beugeling C, Khajehpour M, Snijder EJ, Mark BL, Kikkert M. 2013. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc Natl Acad Sci USA. 110:E838–E847.
   PubMed Web of Science ®Google Scholar
• van Kasteren PB, Beugeling C, Ninaber DK, Frias-Staheli N, van Boheemen S, Garcia-Sastre A, Snijder EJ, Kikkert M. 2012. Arterivirus and nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling. J Virol. 86:773–785.
   PubMed Web of Science ®Google Scholar
• Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, Liu X, Li K, Chen H, et al. 2011. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol. 85:3758–3766.
   PubMed Web of Science ®Google Scholar
• Wang D, Fang L, Luo R, Ye R, Fang Y, Xie L, Chen H, Xiao S. 2010. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem Biophys Res Commun. 399:72–78.
   PubMed Web of Science ®Google Scholar
• Wang G, Chen G, Zheng D, Cheng G, Tang H. 2011. PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway. PLoS One. 6:e17192.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao W, Zhang M, Wang P, Zhao K, Zhao X, Yang S, Gao C. 2013. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J Virol. 87:4507–4515.
   PubMed Web of Science ®Google Scholar
• Wang Q, Huang L, Hong Z, Lv Z, Mao Z, Tang Y, Kong X, Li S, Cui Y, Liu H, et al. 2017. The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response. PLoS Pathog. 13:e1006264.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu X, Cui Y, Tang Y, Chen W, Li S, Yu H, Pan Y, Wang C. 2014. The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity. 41:919–933.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang K, Li J, Zheng C. 2013. Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. J Virol. 87:11851–11860.
   PubMed Web of Science ®Google Scholar
• Wei R, Liu X, Yu W, Yang T, Cai W, Liu J, Huang X, Xu GT, Zhao S, Yang J, et al. 2015. Deubiquitinases in cancer. Oncotarget. 6:12872–12889.
   PubMed Web of Science ®Google Scholar
• West JA, Wicks M, Gregory SM, Chugh P, Jacobs SR, Zhang Z, Host KM, Dittmer DP, Damania B. 2014. An important role for mitochondrial antiviral signaling protein in the Kaposi's sarcoma-associated herpesvirus life cycle. J Virol. 88:5778–5787.
   PubMedGoogle Scholar
• Xing Y, Chen J, Tu J, Zhang B, Chen X, Shi H, Baker SC, Feng L, Chen Z. 2013. The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. J Gen Virol. 94:1554–1567.
   PubMed Web of Science ®Google Scholar
• Yan J, Li Q, Mao AP, Hu MM, Shu HB. 2014. TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J Mol Cell Biol. 6:154–163.
   PubMed Web of Science ®Google Scholar
• Ye R, Su C, Xu H, Zheng C. 2017. Herpes simplex virus 1 ubiquitin-specific protease UL36 abrogates NF-kappaB activation in DNA sensing signal pathway. J Virol. 91:e02417-16.
   PubMed Web of Science ®Google Scholar
• Yokota S, Okabayashi T, Yokosawa N, Fujii N. 2008. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J. 22:74–83.
   PubMed Web of Science ®Google Scholar
• Zeng W, Xu M, Liu S, Sun L, Chen ZJ. 2009. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell. 36:315–325.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang D, Zhong H, Luo R, Shang M, Liu D, Chen H, Fang L, Xiao S. 2015. Ubiquitin-specific protease 15 negatively regulates virus-induced Type I interferon signaling via catalytically-dependent and -independent mechanisms. Sci Rep. 5:11220.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu MM, Wang YY, Shu HB. 2012. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J Biol Chem. 287:28646–28655.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao X, Zhang M, Zhao W, Gao C. 2014. Ubiquitin-specific protease 2b negatively regulates IFN-β production and antiviral activity by targeting TANK-binding kinase 1. J Immunol. 193:2230–2237.
   PubMed Web of Science ®Google Scholar
• Zhang M, Lee AJ, Wu X, Sun SC. 2011. Regulation of antiviral innate immunity by deubiquitinase CYLD. Cell Mol Immunol. 8:502–504.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wu X, Lee AJ, Jin W, Chang M, Wright A, Imaizumi T, Sun SC. 2008. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem. 283:18621–18626.
   PubMed Web of Science ®Google Scholar
• Zhong H, Wang D, Fang L, Zhang H, Luo R, Shang M, Ouyang C, Ouyang H, Chen H, Xiao S. 2013. Ubiquitin-specific proteases 25 negatively regulates virus-induced type I interferon signaling. PLoS One. 8:e80976.
   PubMed Web of Science ®Google Scholar
• Zinngrebe J, Montinaro A, Peltzer N, Walczak H. 2014. Ubiquitin in the immune system. EMBO Rep. 15:28–45.
   PubMed Web of Science ®Google Scholar